J. D. den Dunnen

发表

Construction of dystrophin fusion proteins to raise targeted antibodies to different epitopes

A. Moorman, G. van Ommen, G. Morris, 1992, FEBS letters.

Recurrence risk due to germ line mosaicism: Duchenne and Becker muscular dystrophy

J. Houwing-Duistermaat, J. D. den Dunnen, E. Bakker, 2009, Clinical genetics.

Skewed X-inactivation is common in the general female population

A. Uitterlinden, F. Hormozdiari, D. Cox, 2018, European Journal of Human Genetics.

Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration

J. Teague, A. Langerød, S. Forbes, 2009, Human mutation.

Duplications in the DMD gene

J. T. Dunnen, R. Weiss, K. Flanigan, 2006, Human mutation.

Nomenclature for the description of human sequence variations

S. Antonarakis, J. T. Dunnen, J. den Dunnen, 2001, Human Genetics.

Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting

M Schwab, D. Nickerson, M. Relling, 2016, Clinical pharmacology and therapeutics.

Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort

J. T. Dunnen, R. Weiss, D. Dunn, 2005, American journal of medical genetics. Part A.

Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling

P. Hoen, R. Turk, E. Sterrenburg, 2005, BMC Genomics.

The InSiGHT database: utilizing 100 years of insights into Lynch Syndrome

M. Woods, J. D. Dunnen, P. Peltomäki, 2013, Familial Cancer.

Recommendations for locus‐specific databases and their curation

M. Vihinen, J. Beckmann, A. Brookes, 2008 .

Relative power and sample size analysis on gene expression profiling data

M. van Iterson, P. 't Hoen, P. Pedotti, 2009, BMC Genomics.